Raymond James lowered the firm’s price target on Omega Healthcare (OHI) to $42 from $44 and keeps an Outperform rating on the shares. Omega Healthcare posted strong Q1 results and increased 2025 guidance that bracketed expectations, the analyst tells investors in a research note. The otherwise “pristine” quarter was marred by issues at Genesis, which failed to pay rent/interest in March, though did pay in April and also May, and is expected to pay in June, the firm says.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on OHI:
- Omega Healthcare, Sunbound announce strategic partnership
- Omega Healthcare Revises Operator Updates Slide
- Omega Healthcare Investors Reports Strong Q1 2025 Results
- Omega Healthcare Investors: Strong Growth Amid Challenges
- Positive Outlook for Omega Healthcare: Strong Financial Performance and Strategic Developments Justify Buy Rating
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue